Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,934 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase I trial of combretastatin A4 phosphate (CA4P) in combination with bevacizumab in patients with advanced cancer.
Nathan P, Zweifel M, Padhani AR, Koh DM, Ng M, Collins DJ, Harris A, Carden C, Smythe J, Fisher N, Taylor NJ, Stirling JJ, Lu SP, Leach MO, Rustin GJ, Judson I. Nathan P, et al. Among authors: ng m. Clin Cancer Res. 2012 Jun 15;18(12):3428-39. doi: 10.1158/1078-0432.CCR-11-3376. Epub 2012 May 29. Clin Cancer Res. 2012. PMID: 22645052 Clinical Trial.
A phase II, randomised study of mFOLFOX6 with or without the Akt inhibitor ipatasertib in patients with locally advanced or metastatic gastric or gastroesophageal junction cancer.
Bang YJ, Kang YK, Ng M, Chung HC, Wainberg ZA, Gendreau S, Chan WY, Xu N, Maslyar D, Meng R, Chau I, Ajani JA. Bang YJ, et al. Among authors: ng m. Eur J Cancer. 2019 Feb;108:17-24. doi: 10.1016/j.ejca.2018.11.017. Epub 2018 Dec 25. Eur J Cancer. 2019. PMID: 30592991 Clinical Trial.
Trends of antiseizure medication utilization among pregnant people in four Canadian provinces from 1998 to 2023; a study from the Canadian mother-child cohort active surveillance initiative (CAMCCO).
Peymani P, Berard A, Winquist B, Kaul P, Sheehy O, Lavu A, Leong C, Falk J, Delaney JA, Kowalec K, Ng M, Ruth C, Aboulatta L, Alessi-Severini S, Dragan R, Derksen S, Barrett O, Shams G, Eltonsy S. Peymani P, et al. Among authors: ng m. Front Pharmacol. 2024 Nov 12;15:1469552. doi: 10.3389/fphar.2024.1469552. eCollection 2024. Front Pharmacol. 2024. PMID: 39600367 Free PMC article.
Autologous Epstein-Barr virus-specific adoptive T-cell therapy in a patient with lupus nephritis.
Ranganathan D, Leibowitz S, John GT, Neller MA, Ambalathingal GR, Beagley L, Panikkar A, Best S, Raju J, Reddiex H, Ratanjee S, Ng MSY, Smith C, Khanna R. Ranganathan D, et al. Among authors: ng msy. Clin Transl Immunology. 2024 Nov 19;13(11):e70015. doi: 10.1002/cti2.70015. eCollection 2024. Clin Transl Immunology. 2024. PMID: 39564002 Free PMC article.
2,934 results